Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses
- 1 October 1996
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (10) , 1323-1328
- https://doi.org/10.1007/bf01367587
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood samplingEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Benzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenilEuropean Journal of Pharmacology, 1993
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentAnnals of Neurology, 1991
- Quantitative assessment of cortical synaptic density in Alzheimer's diseaseNeurobiology of Aging, 1990
- Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer diseaseNeuroscience Letters, 1989
- Synaptic loss in Alzheimer's disease and other dementiasNeurology, 1989
- A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's diseaseJournal of the Neurological Sciences, 1987
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Selective antagonists of benzodiazepinesNature, 1981
- Two Methods for Calculating Regional Cerebral Blood Flow from Emission Computed Tomography of Inert Gas ConcentrationsJournal of Computer Assisted Tomography, 1979